Frequent Mutation of Isocitrate Dehydrogenase<i>(IDH)1</i>and<i>IDH2</i>in Cholangiocarcinoma Identified Through Broad-Based Tumor GenotypingDarrell R. Borger, A. John Iafrate, Valeria R. Fantin et al.|The Oncologist|2011Cited by 724
Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic CholangiocarcinomaDarrell R. Borger, Andrew X. Zhu, Lipika Goyal et al.|Clinical Cancer Research|2014Cited by 138